• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于网络和基于小组的行为干预在真实临床环境中对非酒精性脂肪性肝病的长期随访。

Long-term follow-up of web-based and group-based behavioural intervention in NAFLD in a real world clinical setting.

机构信息

IRCCS-Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Department of Medical Sciences, Division of Gastroenterology and Hepatology, A.O. Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy.

出版信息

Aliment Pharmacol Ther. 2024 Jan;59(2):249-259. doi: 10.1111/apt.17768. Epub 2023 Oct 16.

DOI:10.1111/apt.17768
PMID:37843741
Abstract

BACKGROUND

The long-term results of web-based behavioural intervention in non-alcoholic fatty liver disease (NAFLD) have not been described in patients followed in specialised centres.

AIMS

To analyse the long-term effectiveness of web education compared with the results achieved by a group-based behavioural intervention in the same years 2012-2014.

METHODS

We followed 679 patients with NAFLD (web-based, n = 290; group-based, n = 389) for 5 years. Weight loss ≥10% was the primary outcome; secondary outcomes were attrition, changes in liver enzymes and in biomarkers of steatosis (Fatty liver Index) and fibrosis (Fibrosis-4 index).

RESULTS

The cohorts differed in age, education, working status and presence of diabetes. Attrition was higher in the web-based cohort (hazard ratio: 1.53; 95% CI: 1.24-1.88), but not different after adjustment for confounders. Among patients in active follow-up, 50% lost ≥5% of initial body weight and 19% lost ≥10%, without difference between cohorts. Alanine aminotransferase levels fell to within the normal range in 51% and 45% of web- and group-based cohorts, respectively. Fatty Liver Index declined progressively and, by year 5, it ruled out steatosis in 4.8%, whereas 24.9% were in the indeterminate range. Fibrosis-4 index increased in both cohorts, driven by age, but the prevalence of cases ruling-in advanced fibrosis remained very low (around 1%). Improvements in the class of both surrogate biomarkers were associated with ≥5% weight loss.

CONCLUSIONS

Although burdened by attrition, web-based behavioural intervention is feasible and effective in NAFLD, expanding the cohort involved in behavioural programs and reducing the risk of progressive disease.

摘要

背景

在专门中心随访的患者中,尚未描述基于网络的非酒精性脂肪性肝病(NAFLD)行为干预的长期结果。

目的

分析与同年(2012-2014 年)进行的基于小组的行为干预相比,网络教育的长期有效性。

方法

我们随访了 679 例 NAFLD 患者(网络组,n=290;基于小组的干预组,n=389),随访时间为 5 年。体重减轻≥10%是主要结果;次要结果是流失、肝酶变化以及脂肪变性(脂肪肝指数)和纤维化(纤维化 4 指数)的生物标志物变化。

结果

两组在年龄、教育程度、工作状态和糖尿病的存在方面存在差异。网络组的流失率更高(风险比:1.53;95%可信区间:1.24-1.88),但在调整混杂因素后无差异。在积极随访的患者中,50%的患者减轻了初始体重的≥5%,19%的患者减轻了≥10%,两组之间没有差异。丙氨酸氨基转移酶水平降至正常范围,网络组和基于小组的干预组分别为 51%和 45%。脂肪肝指数逐渐下降,到第 5 年,排除脂肪变性的患者比例为 4.8%,而不确定范围的患者比例为 24.9%。纤维化 4 指数在两个队列中均增加,主要由年龄驱动,但诊断为晚期纤维化的病例比例仍然很低(约 1%)。替代生物标志物类别的改善与≥5%的体重减轻相关。

结论

尽管存在流失,但基于网络的行为干预在 NAFLD 中是可行且有效的,扩大了参与行为项目的患者群体,并降低了疾病进展的风险。

相似文献

1
Long-term follow-up of web-based and group-based behavioural intervention in NAFLD in a real world clinical setting.基于网络和基于小组的行为干预在真实临床环境中对非酒精性脂肪性肝病的长期随访。
Aliment Pharmacol Ther. 2024 Jan;59(2):249-259. doi: 10.1111/apt.17768. Epub 2023 Oct 16.
2
An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers.基于互联网的非酒精性脂肪性肝病患者生活方式改变方法:对体重减轻和替代标志物的两年影响。
J Hepatol. 2018 Nov;69(5):1155-1163. doi: 10.1016/j.jhep.2018.07.013. Epub 2018 Oct 2.
3
Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.生活方式干预对非肥胖非酒精性脂肪性肝病患者的有益影响。
J Hepatol. 2018 Dec;69(6):1349-1356. doi: 10.1016/j.jhep.2018.08.011. Epub 2018 Aug 22.
4
Multidisciplinary lifestyle intervention is associated with improvements in liver damage and in surrogate scores of NAFLD and liver fibrosis in morbidly obese patients.多学科生活方式干预与病态肥胖患者的肝损伤改善以及非酒精性脂肪性肝病和肝纤维化的替代评分改善相关。
Eur J Nutr. 2022 Aug;61(5):2725-2735. doi: 10.1007/s00394-022-02846-7. Epub 2022 Mar 11.
5
The Fatty Liver Assessment in Germany (FLAG) cohort study identifies large heterogeneity in NAFLD care.德国脂肪肝评估(FLAG)队列研究发现非酒精性脂肪性肝病(NAFLD)护理存在很大差异。
JHEP Rep. 2020 Aug 4;2(6):100168. doi: 10.1016/j.jhepr.2020.100168. eCollection 2020 Dec.
6
Weight Loss After Bariatric Surgery Predicts an Improvement in the Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score.减重手术后体重减轻可预测非酒精性脂肪性肝病(NAFLD)纤维化评分的改善。
Obes Surg. 2019 Apr;29(4):1295-1300. doi: 10.1007/s11695-018-03676-5.
7
Progression of non-alcoholic fatty liver disease and long-term outcomes: A nationwide paired liver biopsy cohort study.非酒精性脂肪性肝病的进展和长期转归:一项全国性配对肝活检队列研究。
J Hepatol. 2023 Dec;79(6):1366-1373. doi: 10.1016/j.jhep.2023.08.008. Epub 2023 Aug 19.
8
Repeated measurements of non-invasive fibrosis tests to monitor the progression of non-alcoholic fatty liver disease: A long-term follow-up study.非侵入性纤维化检测的重复测量以监测非酒精性脂肪性肝病的进展:一项长期随访研究。
Liver Int. 2022 Jul;42(7):1545-1556. doi: 10.1111/liv.15255. Epub 2022 Mar 28.
9
Obesity and Weight Gain Are Associated With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.肥胖和体重增加与非酒精性脂肪性肝病患者肝纤维化进展相关。
Clin Gastroenterol Hepatol. 2019 Feb;17(3):543-550.e2. doi: 10.1016/j.cgh.2018.07.006. Epub 2018 Sep 11.
10
Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis.生活方式干预治疗病态肥胖:对肝脏脂肪变性、炎症和纤维化的影响。
Am J Physiol Gastrointest Liver Physiol. 2018 Sep 1;315(3):G329-G338. doi: 10.1152/ajpgi.00044.2018. Epub 2018 Jun 7.

引用本文的文献

1
Global Trends in Non-Invasive Techniques for the Diagnosis and Monitoring of Nonalcoholic Fatty Liver Disease: A Bibliometric and Visualization Analysis.非酒精性脂肪性肝病诊断与监测的非侵入性技术全球趋势:文献计量与可视化分析
J Multidiscip Healthc. 2025 Jul 26;18:4243-4266. doi: 10.2147/JMDH.S525751. eCollection 2025.
2
The Impact of Weight Loss Programs on BMI Trajectory in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Veterans Health Administration Study.减肥计划对代谢功能障碍相关脂肪性肝病患者BMI轨迹的影响:一项退伍军人健康管理局研究
Am J Gastroenterol. 2024 Mar 27. doi: 10.14309/ajg.0000000000002785.
3
Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease.
代谢功能障碍相关脂肪性肝病患者发生暴食障碍的风险。
Eat Weight Disord. 2023 Dec 6;28(1):100. doi: 10.1007/s40519-023-01628-2.
4
The Involvement of Calcium Channels in the Endoplasmic Reticulum Membrane in Nonalcoholic Fatty Liver Disease Pathogenesis.内质网膜钙通道在非酒精性脂肪性肝病发病机制中的作用
Cureus. 2023 Nov 20;15(11):e49150. doi: 10.7759/cureus.49150. eCollection 2023 Nov.